Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Abeona Therapeutics (ABEO) over the last 14 years, with Q3 2025 value amounting to $488000.0.

  • Abeona Therapeutics' Other Operating Expenses changed N/A to $488000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $588000.0, marking a year-over-year change of. This contributed to the annual value of $540000.0 for FY2023, which is 9115.91% down from last year.
  • Abeona Therapeutics' Other Operating Expenses amounted to $488000.0 in Q3 2025.
  • Abeona Therapeutics' 5-year Other Operating Expenses high stood at $32.5 million for Q4 2021, and its period low was -$1.1 million during Q2 2022.
  • In the last 4 years, Abeona Therapeutics' Other Operating Expenses had a median value of $100000.0 in 2025 and averaged $3.1 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 73333.33% in 2022, then surged by 681666.67% in 2023.
  • Quarter analysis of 4 years shows Abeona Therapeutics' Other Operating Expenses stood at $32.5 million in 2021, then crashed by 96.77% to $1.0 million in 2022, then crashed by 97.14% to $30000.0 in 2023, then soared by 1526.67% to $488000.0 in 2025.
  • Its Other Operating Expenses stands at $488000.0 for Q3 2025, versus $100000.0 for Q2 2025 and $30000.0 for Q3 2023.